Resectable Pancreatic Acinar Cell Carcinoma
1 clinical trials · Condition
◉ Watch Resectable Pancreatic Acinar Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation (NCT04858334) | National Cancer Institute (NCI) | 2021-06-22 |
Track Resectable Pancreatic Acinar Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.